Narus Financial Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 1698091 SALT LAKE CITY, UT

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$600,916

+$98,732 QoQ

Shares Held

2,388

+3.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#3,007

of 4,153 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Narus Financial Partners, LLC holds $2,295,659 across 6 Drug Manufacturers - General names. ABBV ranks #1 (26.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	2,388	$600,916
2	LLY	ELI LILLY & Co	437	$524,150
3	BMY	Bristol Myers Squibb Co	6,636	$382,366
4	NVS	Novartis AG	1,889	$296,044
5	JNJ	Johnson & Johnson	1,024	$260,065
6	AMGN	Amgen Inc	641	$232,118

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$600,916	2,388	+3.4%	Shares	Sole	2026-07-31
2026-03-31	$502,184	2,309	+9.7%	Shares	Sole	2026-04-21
2025-12-31	$480,742	2,104	+0.4%	Shares	Sole	2026-02-09
2025-09-30	$485,076	2,095	+3.7%	Shares	Sole	2026-02-09
2025-06-30	$374,952	2,020	+1.6%	Shares	Sole	2025-07-14
2025-03-31	$416,525	1,988	+25.3%	Shares	Sole	2025-04-30
2024-12-31	$282,009	1,587	-34.1%	Shares	Sole	2025-01-23
2024-09-30	$475,531	2,408	+8.4%	Shares	Sole	2024-10-18
2024-06-30	$380,945	2,221	+11.1%	Shares	Sole	2024-07-17
2024-03-31	$364,017	1,999	+6.6%	Shares	Sole	2024-04-18
2023-12-31	$290,568	1,875	+11.7%	Shares	Sole	2024-01-25
2023-09-30	$250,271	1,679	+8.8%	Shares	Sole	2023-10-30
2023-06-30	$207,888	1,543	+0.1%	Shares	Sole	2023-08-30
2023-03-31	$245,589	1,541	0.0%	Shares	Sole	2023-06-27
2022-12-31	$249,041	1,541	+8.5%	Shares	Sole	2023-10-12
2022-03-31	$230,196	1,420	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.